Connect with us

Health

Wearable Health Devices Move Toward Medical Applications

Published

on

Wearable health gadgets, once confined to tracking fitness goals, are rapidly evolving into tools that straddle the line between wellness and clinical care. Devices like the Oura ring and Apple Watch now offer advanced monitoring capabilities powered by miniaturized sensors and artificial intelligence (AI), promising users deeper insights into their health.

At the 2024 Web Summit in Lisbon, Oura CEO Tom Hale described this shift, explaining how wearables could transform healthcare by providing continuous health monitoring. “Going to a doctor for medical information is inadequate and inefficient. Devices like ours can act as a ‘doctor in your pocket,’ offering real-time, personalized health insights,” Hale said.

Beyond Wellness: Entering Regulated Healthcare

The wellness sector has boomed in recent years, partly because it bypasses the stringent regulations governing medical devices. However, companies like Oura and Apple are moving into the regulated health space, aiming to differentiate themselves from unverified or low-quality products.

“We’re at the boundary between clinical and wellness devices,” Hale noted. To solidify its standing, Oura has launched a randomized controlled clinical trial in Finland. The study will evaluate whether exercise guidance tailored by the Oura ring’s AI can help reduce arterial stiffness—a key marker of cardiovascular health—compared to standard fitness classes or no intervention.

Early Detection and Preventative Care

Wearables like the Oura ring could play a significant role in preventative health care by detecting physiological changes early. For instance, during the COVID-19 pandemic, Oura’s sensors tracked deviations in users’ health data, enabling an algorithm to predict infections nearly three days before testing.

See also  Loneliness Linked to Higher Death Risk Among Cancer Patients, Global Study Finds

“If we can monitor deviations from a user’s baseline, we can prompt them to seek medical advice early,” Hale explained. He likened the device to a “check engine light” for the body.

Challenges and Skepticism

Despite their promise, wearable devices face hurdles in proving their efficacy for managing health conditions. Currently, no wearables, including Oura, have regulatory approval in Europe or the United States for medical use. Critics argue that obsessing over health metrics could lead to anxiety and that integrating wearable data into clinical care remains a challenge.

Research results are mixed. A 2022 review found that wearables improved physical activity and weight loss but had little effect on blood pressure or cholesterol. Meanwhile, a 2024 meta-analysis showed promise in disease detection, including atrial fibrillation and COVID-19, but emphasized the need for further studies.

The Road Ahead

Hale is optimistic that wearables can help users identify unhealthy habits and inspire positive change. However, ongoing research, such as the Finnish trial, will determine whether devices like the Oura ring can fully bridge the gap between personal wellness tools and clinical medical devices.

Health

More Europeans Take Up Sport, but Major Gaps Remain Across Countries

Published

on

More Europeans are exercising regularly than they were four years ago, but participation continues to vary sharply depending on where people live, their age, education and financial circumstances, according to a new European Commission survey.

The latest Eurobarometer survey on sport and physical activity found that 39% of respondents said they never exercise or play sport, down from 45% in 2022. Nearly half of the 26,508 people surveyed said they exercise or play sport every day or several times a week.

The results also showed wide differences between countries. Finland recorded the highest share of people exercising daily, at 21%, followed by Denmark at 20%. In both countries, another 59% of respondents said they exercise several times a week.

At the other end of the scale, 68% of respondents in Portugal said they never exercise or play sport. Greece and Romania followed, with 66% in each country reporting that they never take part in sport or exercise.

Time was the most commonly cited barrier among people who wanted to exercise more, with 37% identifying it as an obstacle. A lack of motivation or interest was mentioned by 26%, while 15% pointed to health problems or injury. Cost was cited by 12%.

Education and household finances were also closely linked to participation. Some 59% of people who continued their education until at least the age of 20 said they exercise or play sport several times a week. That compared with 23% among those who left education at 15 or younger.

Financial circumstances showed a similar divide. People who said they had the greatest difficulty paying their bills were twice as likely to report never exercising as those who rarely or never faced financial difficulties, at 54% compared with 26%.

See also  Patchy European Laws Leave Thousands of Eggs and Embryos in Limbo

“More Europeans are getting active, but the opportunity to take part still depends too much on income, age and education,” said Roxana Mînzatu, Executive Vice-President for Social Rights and Skills, Quality Jobs and Preparedness.

The survey also highlighted a significant age gap. Nearly three-quarters of people aged 15 to 24 exercise or play sport at least several times a week, compared with 25% of those aged 75 and over. Health problems or injury were the main barrier for older respondents, while younger and middle-aged people were more likely to cite a lack of time.

Physical activity linked to everyday life also increased. Active commuting rose from 24% in 2022 to 37%, while 72% of respondents said they now walk for at least 10 minutes at a time.

The survey found, however, that some Europeans do not consider their neighbourhoods suitable for walking or cycling, potentially restricting opportunities for active travel.

Mînzatu said affordable sport and safe places to exercise should be available close to where people live, including for children from families unable to afford club fees, older people and those with disabilities.

Continue Reading

Health

Congenital Infections Linked to Higher Risks of Autism and Intellectual Disability

Published

on

Children born with certain infections acquired during pregnancy face substantially higher risks of autism and intellectual disability later in life, according to a study of more than 3.7 million people in Sweden.

Researchers found that children with congenital infections were about three times more likely to be diagnosed with autism and more than seven times more likely to receive a diagnosis of intellectual disability than those without such infections.

The findings suggest that infections transmitted from a pregnant woman to her foetus may have lasting effects on brain development, although the study identifies an association rather than proving that the infections directly cause autism or intellectual disability.

The research focused on TORCH infections, a group that includes syphilis, rubella, toxoplasmosis, cytomegalovirus and herpesvirus. These infections can cross the placenta and affect the developing foetus, potentially increasing the risk of miscarriage, stillbirth and other pregnancy complications.

“Although these congenital infections are rare, some of them can be prevented, which makes them important from a public health perspective,” said Reneé Gardner of the Department of Global Public Health at Karolinska Institutet, who contributed to the study.

The researchers examined people born in Sweden between 1987 and 2021 and followed them for up to 30 years. Among the 3.7 million participants, 975 had been diagnosed with a congenital TORCH infection.

Although congenital infections accounted for only a small proportion of autism cases across the population, the risk among affected children was considerably higher. The researchers estimated that about one in five children born with a TORCH infection could later develop autism.

See also  Moderate Coffee Consumption Linked to Healthier Aging, But Experts Urge Caution

The study also found elevated risks of intellectual disability across different levels of severity. The risk of severe to profound intellectual disability was as much as 30 times higher among children with a congenital infection than among those without one.

The researchers found evidence of an impact on educational outcomes even among people who were not diagnosed with autism or intellectual disability. A total of 420 participants with a TORCH infection showed poor school performance without receiving either diagnosis.

Congenital cytomegalovirus, or CMV, is the most common of these infections globally and affects roughly one in 150 newborns. Its burden is substantially greater in low- and middle-income countries.

The researchers said the findings highlight the importance of prevention, particularly in regions where these infections are more common. They pointed to vaccination programmes and other preventive measures as important tools for reducing congenital infections.

They also called for improved identification of affected newborns. Current screening systems, including those used in Sweden, may miss asymptomatic infections because universal screening for TORCH infections is not routinely carried out.

The authors said stronger screening and prevention strategies could help identify children at risk earlier and improve long-term support and care.

Continue Reading

Health

AI Chatbots Make Faster, Less Nuanced Kidney Transplant Decisions Than Doctors

Published

on

Artificial intelligence chatbots may make faster and more confident decisions than human doctors when determining which patient should receive a life-saving kidney transplant, but a new study found that the systems often rely on fewer factors and show less sensitivity to the ethical complexity of such choices.

Researchers from Penn State University in the United States compared decisions made by large language models (LLMs) with choices made by people in earlier studies on kidney allocation. The researchers presented AI models with hypothetical cases based on existing datasets in which human participants had previously chosen between two patients competing for a single available kidney.

The patients were described using characteristics including age, health and drinking habits. Both were considered eligible for the transplant, requiring the decision maker to determine which patient should receive the available organ.

The researchers tested the AI systems in several ways. Some scenarios focused on individual characteristics, while others combined several traits to examine how the models handled competing considerations. In some tests, participants and AI systems were also given the option of flipping a coin, allowing researchers to assess indecision as part of moral decision-making.

Human participants generally placed greater importance on age, often favouring younger patients over older patients. Many of the AI models, however, placed greater weight on lower alcohol consumption.

Hadi Hosseini, the study’s lead researcher at Penn State University, said the findings showed that AI chatbots can diverge from human values when weighing characteristics of patients.

The researchers found that human decisions tended to consider several factors together and were more sensitive to context. LLMs, by contrast, frequently focused on a single characteristic when making their choices.

See also  Functional Beverages Gain Ground Amid Wellness Craze, But Experts Question Health Claims

Another difference involved uncertainty. Human participants were more likely to recognise that organ allocation can involve competing ethical considerations and that there may not be one objectively correct answer. AI models generally showed little hesitation and committed to one choice.

John Dickerson, chief executive officer of Mozilla.ai and a collaborator on the study, said humans recognise ambiguity when allocating scarce resources and use debate to shape how such decisions are made.

The findings come as AI systems are increasingly being used in healthcare for clinical workflows, diagnosis, treatment planning and decisions involving limited medical resources.

The researchers said kidney allocation presents a particularly important test because decisions over deceased-donor and living-donor organs involve medical, ethical and moral considerations.

Hosseini said the ethical stakes are high because decisions involving organ allocation can directly affect patients’ lives. He stressed that the study was not intended to encourage replacing professional medical judgment with AI.

Instead, the researchers said understanding how AI systems behave in high-stakes situations is becoming increasingly important as individuals, organisations and businesses use AI to make decisions or provide recommendations.

Continue Reading

Trending